Table 1. The synergistic effect of matrix metalloproteinase inhibitor combined with docetaxel on PC-3 cells viability.

SB-3CT Concentration (μmol/L)	Docetaxel (nmol/L)
	0.1	1	10	100	1000
5	3.2263	2.1191	0.3592	0.7266	5.6172
10	31.7420	6.6903	1.0189	0.9097	6.5487
20	0.9652	0.8732	0.6837	0.5995	0.7743